COFACTORY LIMITED
COFACTORY LIMITED is a privately-held Manchester-based scientific consultancy that provides technology, product, business, and strategy development advisory services to biotech startups, academic spinouts, and government innovation programs across the UK.
- Company typePrivate
- Founded2018
- HeadquartersGlossop, United Kingdom
- Headcount1–10
- GTM typeB2B
- OfferingServices
What COFACTORY LIMITED does
COFACTORY LIMITED is a privately-held, boutique scientific consulting firm registered in England and Wales, operating from Manchester, UK. Founded in 2018 by Dr Paul Dobson (PhD Computational Biology) and Dr William Rowe (PhD Chemical Engineering), the firm delivers four interlocking service lines to biotech and life-sciences clients: Technology Development (Bioinformatics, AI, Cheminformatics, Process Modelling, Structural & Systems Biology, Chemometrics), Product Development (customer profiling, marketing strategy, sales channels, funnels, soft launches, pricing), Business Development (pitching, grants, fundraises, exits), and Strategy Development (technology transfer and commercialization infrastructure). Primary customer segments are academic spinouts, biotech startups, and — to a lesser extent — large multinationals seeking product management and AI capability support.
The firm's technology backbone is an interdisciplinary scientific platform spanning Life Sciences, Chemistry, Computer Science, and Process Engineering. AI is applied across engagements in the form of protein expression design, computer vision for cell phenotyping, knowledge graphs built on genome annotations, metabolic network reconstruction, and closed-loop optimization of cell culture media. Notable technical contributions include the AI-led protein expression design platform co-developed with Daresbury Proteins, the AI image analysis stack that supported ValitaCell's acquisition by Beckman Coulter Life Sciences in 2022, and the CELLIMAGE consortium that produced Intel's AI Connect for Scientific Data (AiCSD). The firm's R&D output is supported by more than 50 peer-reviewed publications from the founders and over £8M in non-dilutive grant funding secured for partners across multiple projects.
Commercially, Cofactory runs a freemium-to-advisory model: startups receive free initial consultations and advice, with monetisation occurring later through paid advisory positions, project-based technology development, and longer-term consulting engagements. The firm does not publish pricing, derives revenue from professional services across grant-funded projects, startup mandates, and government commissions, and operates without institutional investment. Geographic focus is the United Kingdom, particularly the NW England biotech cluster, with targeted international collaborations (Ireland via CELLIMAGE/DTIF, EU/multinational projects via Intel and Waters). Customers span startups (Daresbury Proteins, ValitaCell, Multus Biotechnology, CELLIMAGE), government programs (InnovateUK, UK Medicines Discovery Catapult, LYVA Labs, iiCON), and academic institutions (University of Salford/IBIC, Liverpool School of Tropical Medicine).
COFACTORY LIMITED firmographics
Firmographics- Name
- COFACTORY LIMITED
- Legal name
- COFACTORY LTD
- Website
- https://cofactory.co.uk
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- COFACTORY LIMITED is a privately-held Manchester-based scientific consultancy that provides technology, product, business, and strategy development advisory services to biotech startups, academic spinouts, and government innovation programs across the UK.
- Ownership category
- akta.pro rank
COFACTORY LIMITED industry classification
Industry- Product category
- Biotech Consulting
- NAICS
- Other Scientific and Technical Consulting Services (54169), Management Consulting Services (54161), Professional, Scientific, and Technical Services (54)
- SIC
- Services-Management Consulting Services (8742), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- CMC, Process Development & Tech Transfer Staffing FSP (HLAGAOAK)
- akta.pro secondary industry
- Laboratory, Bioanalytical & Central Lab Staffing FSP (HLAGAOAI)
Keywords
Where COFACTORY LIMITED is headquartered
LocationHeadquarters
- HQ city
- Glossop
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
COFACTORY LIMITED business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Advisory Services: Paid advisory positions and services after initial free consultations. The company states their payoff comes through paid advisory positions and services rather than upfront charging.
- Technology Development Projects: Project-based technology development work across Bioinformatics, AI, and Process Modelling for biotech partners
- Product Development Consulting: Support for customer profiling, marketing strategy, sales channels, soft launches, and pricing
- Business Development Advisory: Support for spinouts and startups on pitching, grants, fundraises, and exits
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Multi-year contract | Free initial consultation for startups |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
COFACTORY LIMITED product offering
Product offeringCore offering
Cofactory provides interdisciplinary scientific consulting services to biotech and life sciences companies. Its work spans four service lines: Technology Development (Bioinformatics, AI, Cheminformatics, Process Modelling), Product Development (customer profiling, marketing, sales channels, soft launches, pricing), Business Development (pitching, grants, fundraising, exits), and Strategy Development (technology transfer and commercialisation infrastructure). The firm operates across all Technology Readiness Levels (TRLs) and supports academic spinouts, startups, and multinational clients.
Product overview
COFACTORY LIMITED is a consultancy firm providing interdisciplinary scientific advisory services to biotech companies, not a traditional product company. The core offerings consist of four service lines: Technology Development (Bioinformatics, AI, Process Modelling), Product Development (customer profiling, marketing, sales), Business Development (pitching, grants, fundraising, exits), and Strategy Development (technology transfer, commercialisation). Projects include AI-led protein expression platforms (Daresbury Proteins), AI analytics for stem cell therapy manufacturing (CELLIMAGE), and biopharma market expansion support (Multus Biotechnology).
Differentiator
Problem solved
Functional benefit
Products and services
- Technology Development Services
Quantifiable outcome
- Secured >£8M in non-dilutive grant funding for partners
- +3 more outcomes
Companies that use COFACTORY LIMITED
Customer profileNamed customers10 records
Segments3 records
Ideal customer profiles3 records
COFACTORY LIMITED technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability8 records
Feature4 records
COFACTORY LIMITED partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core and minor.
- Beckman Coulter Life SciencescoreAcquired ValitaCell in 2022, where Cofactory built and led the Data Team driving new technology for cell phenotyping and AI image analysis. Cofactory also supported ValitaCell's soft product launches and exit process.
- Daresbury ProteinscoreJoint InnovateUK BridgeAI grant developing AI-led protein expression design platforms to produce growth factors for Cellular Agriculture and Cell Therapy Manufacturing. The collaboration aims to drive down the cost of proteins needed for Cultivated Meat and Biopharmaceutical manufacturing.
- University of GalwaycoreCELLIMAGE project collaboration funded by Irish government DTIF grant to develop AI analytics for Stem Cell Therapy manufacturing. Cofactory ideated and funded the project, built the AI team, and led laboratory and software development interactions.
- IntelcoreTechnology partner in CELLIMAGE project that created AI Connect for Scientific Data (AiCSD) - a connectivity solution for Edge AI workloads developed by Intel based on the project outcomes.
- Multus Biotechnology LtdcoreSupporting expansion into Biopharma by designing marketing content, building customer funnels, overseeing sales strategies, and supporting fundraising efforts. Multus designs cell culture media using lab robotics and AI in a closed-loop optimisation platform.
- UK Medicines Discovery CatapultminorCommissioned to report on Sustainability issues and opportunities in Biopharmaceutical Manufacturing, with findings that the majority of emissions are associated with energy costs of filtering air (HVAC) and water (water-for-injection grade).
- University of Salford & IBICminorSupported IBIC Relationship Development project to help university academics align around a business canvas and pitch deck to commercialize their Plant Natural Product Extraction expertise.
- LYVA LabsminorLiverpool City Region's Innovation Agency. Provided domain expertise to profile Industrial Biotechnology academics, companies and stakeholders, formulating plans to increase academic-company interactions and support bioprocess scaleup.
- iiCONminorPartnership to understand Data Science and Informatics barriers holding back microbiome research translation. Designed and led three workshops on Personal Care; Food, Water and the Process Industries; and One Health.
- Liverpool School of Tropical MedicinecoreBRITE initiative led by LSTMED, funded by Research England, to drive biopharmaceutical manufacturing in NW England. Cofactory is part of this new initiative.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
COFACTORY LIMITED competitors and assessment
Company assessmentBroad incumbents
- Dotmatics: Enterprise scientific R&D platform combining software, data, and services for life sciences. Overlaps with Cofactory's informatics, data, and AI integration offerings but at much larger scale and with proprietary software assets.
- Baringa Partners: UK-based independent consulting firm with significant life sciences and energy practices. Comparable in client base (UK corporates, government-linked initiatives) and consulting-driven model, though much broader in scope.
- Cambridge Consultants: Deep-tech product development and consulting firm with significant biotech and process engineering capabilities. Comparable to Cofactory's interdisciplinary Life Sciences/Computer Science/Process Engineering model but at much larger scale.
- Kinapse (Syneos Health Consulting): Global life sciences consulting firm (now part of Syneos) offering strategy, regulatory, and operational advisory to pharma and biotech. Comparable in advisory nature but vastly larger in scale and operating globally.
Direct peers
- Cresset (Discovery Services): UK-based scientific software and services firm specializing in cheminformatics, computational chemistry, and molecular design. Directly comparable to Cofactory's cheminformatics, computational biology, and AI/Process Modelling capabilities serving biotech clients.
- Alacrita: UK-based biotech and pharmaceutical consulting firm offering strategic and technical advisory to biotechs and investors. Highly comparable to Cofactory in client profile (spinouts, startups, pharma) and service mix (commercial strategy, due diligence, scientific advisory).
- Oxford BioConsultancy: UK boutique life sciences consulting firm supporting biotech startups, spinouts, and pharma on strategic and scientific issues. Closely comparable to Cofactory in size, focus on academic spinouts, and breadth of advisory services.
Emerging players
- Multus Biotechnology: UK startup using AI and lab robotics to design cell culture media for cultivated meat and biopharma. Functions partly as a Cofactory client (commercial expansion support) but also a thematic peer in AI-driven bioprocess optimization.
Regional players
- Medicines Discovery Catapult: UK Catapult center accelerating drug discovery by providing infrastructure, expertise, and project support to biotechs. Cofactory has been commissioned by MDC, making it both a peer and a prior client; both operate at the intersection of UK biotech translation.
- Cell & Gene Therapy Catapult: UK Catapult accelerating cell and gene therapy commercialization. Highly relevant peer given Cofactory's work on stem cell therapy manufacturing AI analytics (CELLIMAGE) and bioprocessing scaleup support.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
COFACTORY LIMITED social profiles
Digital presenceCOFACTORY LIMITED financial estimates
Financial estimateRevenue estimate
Valuation estimate
COFACTORY LIMITED leadership team
Management profileNumber of profiles
Profiles2 records
COFACTORY LIMITED funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
COFACTORY LIMITED M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about COFACTORY LIMITED
What does COFACTORY LIMITED do?
Cofactory provides interdisciplinary scientific consulting services to biotech and life sciences companies. Its work spans four service lines: Technology Development (Bioinformatics, AI, Cheminformatics, Process Modelling), Product Development (customer profiling, marketing, sales channels, soft launches, pricing), Business Development (pitching, grants, fundraising, exits), and Strategy Development (technology transfer and commercialisation infrastructure). The firm operates across all Technology Readiness Levels (TRLs) and supports academic spinouts, startups, and multinational clients.
Is COFACTORY LIMITED a public or private company?
COFACTORY LIMITED is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was COFACTORY LIMITED founded?
COFACTORY LIMITED was founded in 2018. It employs 1 to 10 people.
Where is COFACTORY LIMITED based?
COFACTORY LIMITED is headquartered in Glossop, United Kingdom, in the Europe region.
How does COFACTORY LIMITED make money?
Four revenue lines are on record. Advisory Services are the primary driver. The others are technology Development Projects, product Development Consulting and business Development Advisory.
Who are COFACTORY LIMITED's main competitors?
Broad incumbents on record are Dotmatics, Baringa Partners, Cambridge Consultants and Kinapse (Syneos Health Consulting). Direct peers are Cresset (Discovery Services), Alacrita and Oxford BioConsultancy. Multus Biotechnology is listed as an emerging player. Regional players are Medicines Discovery Catapult and Cell & Gene Therapy Catapult.
Does COFACTORY LIMITED have an API?
No public API is recorded for COFACTORY LIMITED.
What industry is COFACTORY LIMITED in?
COFACTORY LIMITED's product category is Biotech Consulting. Its primary akta.pro industry code is HLAGAOAK, CMC, Process Development & Tech Transfer Staffing FSP, with a secondary code of HLAGAOAI, Laboratory, Bioanalytical & Central Lab Staffing FSP. Its NAICS code is 54169 and its SIC code is 8742.